HIV: A discovery opening the road to novel scientific knowledge and global health improvement

Virology

Volumn 397, Issue 2, 2010, Pages 255-259

  Barré Sinoussi, Françoise ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LENTIVIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE CONTROL; DISEASE MODEL; HEALTH EDUCATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MEDICAL RESEARCH; MIXED INFECTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; VIRAL GENE THERAPY; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; BIOMEDICAL RESEARCH; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV; HIV INFECTIONS; HUMANS; MALE; MEDICINE; MODELS, BIOLOGICAL;

EID: 75749154473     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.033     Document Type: Article

References (27)

1. Alizon M., et al. Molecular cloning of lymphadenopathy-associated virus. Nature 312 (1984) 757-760
2. Apetrei C., Robertson D.L., and Marx P.A. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front. Biosci. 9 (2004) 225-254
3. Barouch D.H. Challenges in the development of an HIV-1 vaccine. Nature 455 (2008) 613-619
4. Barré-Sinoussi F., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (1983) 868-871
5. Broder S., et al. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet 2 (1985) 627-630
6. Brun-Vezinet F., et al. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1 (1984) 1253-1256
7. Cadogan M., and Dalgleish A.G. HIV immunopathogenesis and strategies for intervention. Lancet Infect. Dis. 8 (2008) 675-684
8. Dalgleish A.G., et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 (1984) 763-767
9. Diop O.M., et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 82 (2008) 5145-5152
10. Douek D.C., Roederer M., and Koup R.A. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 60 (2009) 471-484
11. Gallo R.C., et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224 (1984) 500-503
12. Gottlieb M.S., et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305 (1981) 1425-1431
13. Haynes B.F., and Shattock R.J. Critical issues in mucosal immunity for HIV-1 vaccine development. J. Allergy Clin. Immunol. 122 (2008) 3-9 quiz 10-1
14. Klatzmann D., et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312 (1984) 767-768
15. Klatzmann D., et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225 (1984) 59-63
16. Kornfeld C., et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115 (2005) 1082-1091
17. Levy J.A., et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225 (1984) 840-842
18. Liovat A.S., Jacquelin B., Ploquin M.J., Barre-Sinoussi F., and Muller-Trutwin M.C. African non human primates infected by SIV-why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr. HIV Res. 7 (2009) 39-50
19. Ravet S., et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109 (2007) 4296-4305
20. Saez-Cirion A., et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6776-6781
21. Saez-Cirion A., Pancino G., Sinet M., Venet A., and Lambotte O. HIV controllers: how do they tame the virus?. Trends Immunol. 28 (2007) 532-540
22. + NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS ONE e1975 (2008) 3
23. Silvestri G. AIDS pathogenesis: a tale of two monkeys. J. Med. Primatol. 37 Suppl. 2 (2008) 6-12
24. Simon F., et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4 (1998) 1032-1037
25. Wain-Hobson S., Sonigo P., Danos O., Cole S., and Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 40 (1985) 9-17
26. Walker B.D., and Burton D.R. Toward an AIDS vaccine. Science 320 (2008) 760-764
27. UNAIDS 2008. Global Report on AIDS Epidemic. (2008).